{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-053952","form_type":"8-K","ticker":"AGEN","cik":"0001098972","company_name":"AGENUS INC","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.277732+00:00","generated_at":"2026-06-02T16:00:37.012612+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Agenus reports Q1 net loss $63.5M; announces $100M royalty financing with Ligand","bullets":["Net loss narrowed to $63.5M ($3.04/shr) from $70.9M ($4.31/shr) a year ago; revenue $28M.","Cash and equivalents $52.9M at March 31, 2024, vs $76.1M at Dec 31, 2023; Q1 cash burn $38.2M.","Signed $100M royalty financing with Ligand ($75M initial + $25M option) to fund BOT/BAL launch readiness.","BOT/BAL Phase 1b in r/r MSS CRC NLM (n=77): 23% ORR, median OS 21.2 months, 12-month OS 71%.","Regained Nasdaq compliance after 20:1 reverse stock split in Q1 2024; plan BLA submission for BOT/BAL in H2 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-053952","json":"https://secwatch.observer/filing/0000950170-24-053952.json","markdown":"https://secwatch.observer/filing/0000950170-24-053952.md","text":"https://secwatch.observer/filing/0000950170-24-053952.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1098972/000095017024053952/0000950170-24-053952-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1098972/000095017024053952/agen-20240507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T16:00:37.012612+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"248a20c50bdecabaefe32e8555395dfe360cee37","claim":"AGENUS INC reported financial results for the quarter ended March 31, 2024.","evidence_excerpt":"On May 7, 2024, Agenus Inc. announced its financial results for the quarter ended March 31, 2024. In connection with the announcement, the Company issued a press release, which is being furnished as Exhibit 99.1 to this current report on Form 8-K.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017024053952/0000950170-24-053952-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2024"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}